COMMUNIQUÉS West-GlobeNewswire

Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference
20/02/2019
CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that Gerald [...]
Kura Oncology to Present at SVB Leerink Global Healthcare Conference
20/02/2019
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy [...]
Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity
20/02/2019
TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries ") a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products is [...]
Marinus Pharmaceuticals to Present at the Leerink Healthcare Conference
20/02/2019
RADNOR, Pa., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
20/02/2019
FDA Special Protocol Assessment agreement granted for PRECISION-AF clinical trial evaluating Gencaro as a potential treatment for atrial fibrillation in a heart failure population that has no FDA approved drug therapies [...]
Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions
20/02/2019
Awarded NASA’s 2019 Ames Research Innovation Award HAIFA, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing novel [...]
Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019
20/02/2019
ALPHARETTA, Ga., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy
20/02/2019
With Official Launch and First Implant, Several Health Insurers N ow Consider DBS Therapy for Epilepsy a Covered Indication DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT) today announced both the U.S. launch of [...]
PotBotics: Bringing Big Data to Medical Cannabis -- CFN Media
20/02/2019
Seattle, Washington, Feb. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
20/02/2019
Biohit Oyj Financial Statement Release, 20 February 2019 at 9:30 am local time (EET) SUMMARY January-December 2018 Net sales EUR 9.9 million (EUR 9.0 million) Net sales grew by 10.6% compared to 2017 Operative EBITDA [...]
Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market
20/02/2019
Malmö, February 20, 2019 Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market "After six months at Acarix, I clearly see our market [...]
Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update
20/02/2019
LONDON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Neovacs announces two appointments to its executive committee
20/02/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE COMMITTEE Vincent Serra, PhD – Chief Scientific Officer Valerie Salentey, Pharm D - Head of Regulatory Affairs Paris [...]
Néovacs annonce deux nominations au sein de son comité exécutif
20/02/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE DEUX NOMINATIONS AU SEIN DE SON COMITÉ EXÉCUTIF Vincent Serra, PhD - Directeur Scientifique (CSO) Valérie Salentey, PharmD - Responsable [...]
Canntab Provides Corporate Update
20/02/2019
Moving into FSD Pharma and FSD Processing License Mackie Research Extension Director Estate Planning Initiative OTCQB under symbol CTABF TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL [...]
Vigil Reports Third Quarter Results
20/02/2019
VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the quarter ending December 31, 2018. Developments in the [...]
MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call
20/02/2019
ROCKVILLE, MD, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Chembio Diagnostics to Participate in the BTIG Medical Technology, Life Science and Diagnostic Tools Conference
20/02/2019
MEDFORD, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the Company plans to participate in [...]

Pages